IPHA vs AAPL: Which Stock is Better?
Side-by-side comparison of Innate Pharma Sa and Apple Inc in 2026
IPHA
Innate Pharma Sa
$1.69
AAPL
Apple Inc
$266.65
Key Metrics Comparison
| Metric | IPHA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $152.94M | N/A | IPHA |
| P/E Ratio | N/A | 32.80 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | -0.5% | 0.2% | AAPL |
| Gross Margin | -384.4% | 47.3% | AAPL |
Analyze IPHA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPHA or AAPL a better investment?
Comparing IPHA and AAPL: Innate Pharma Sa has a market cap of $152.94M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPHA and AAPL?
IPHA (Innate Pharma Sa) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPHA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPHA or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.5% for IPHA.
Which company is more profitable: IPHA or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -384.4% for IPHA.
Which is the larger company: IPHA or AAPL?
Innate Pharma Sa (IPHA) is larger with a market cap of $152.94M compared to N/A for AAPL.
Should I buy IPHA or AAPL in 2026?
Both IPHA and AAPL have investment merit. IPHA trades at $1.69 while AAPL trades at $266.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPHA and AAPL stock?
Key differences: Market Cap ($152.94M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (-0.5% vs 0.2%), Gross Margin (-384.4% vs 47.3%).